Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- CA 19.9
- Circulating Tumor Cells
- Circulating Tumor DNA (KRAS)
- Pancreatic Adenocarcinoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02072616
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: David SEFRIOUI, MD UH Rouen